top of page

Globally supply chains for health products are complex everywhere. Strong supply chains are essential for effective health care delivery and form the backbone of a country’s health system.


The COVID-19 pandemic exposed many countries lacking local capabilities and capacity to manufacture and supply the needed personal protective equipment (PPEs) as well as other essential drugs needed by healthcare workers and the general population to curb the effect of the pandemic. Most countries relied heavily on pharmaceutical and medicine imports due to lack of local production capacities, policies favoring importation, high cost of importing raw materials and difficulty achieving economies of scale. 


The pandemic served to deepen already existing socio-economic disparities both within and across African countries - most African countries have been disproportionately impacted by the immense strain on health systems, disruption of supply chains (including vaccines), as well as the economic costs after lockdowns, business closures, and travel restrictions. (resulting in a sudden drop in outward medical tourism).


With 26% of the global disease burden and 16% of the world’s population, sub-Saharan Africa commands less than 2% of the world’s health expenditure. This limited health expenditure has manifested in several deficits across health systems such as Africa’s limited access to vaccines, (including initially COVID-19 vaccines), key drugs, supplies, and even skilled personnel – all of which represent deficits gaps that were further widened by the pandemic.


However, a significant and positive impact of the pandemic on the landscape has been renewed and widespread recognition across key African public and private stakeholders that the current trends in health spending and in investment in health-related facilities, are significantly inadequate to meet Africa’s growing healthcare demands due to the simultaneous demographic, epidemiological and urban transitions being encountered. The Africa Union and Africa CDC publicly disclosed a goal of 60% of vaccines being produced on the continent by 2040 vs. only 1% of vaccines produced locally prior to COVID-19.


The observed increase across the continent in the health and pharmaceutical space is reflected in data from the Africa Private Equity Association and Venture Capital Association (AVCA) shows the healthcare sector is taking a rising share of overall deal value on the continent – 4% in 2018 to 12% in 2019 and 24% in the first half of 2020. This of course, does not include direct investments or consideration of investments by multinational pharmaceuticals or hospital groups in the continent.


The current conversations led by various entities around regional purchasing of manufacturing of vaccines may indicate a change in political will, and the potential opportunity for a major game changer in the African Continental Free Trade Area (AfCFTA). The AfCFTA could be a key milestone for economic integration of Africa with an estimated a market of 1.3 billion people, a Gross Domestic Product (GDP) of $2.5 trillion, across 55 member states of the AU.


The increased funding into the sector may further exacerbate problems that besiege the sector are directly related to supply chain inefficiencies, poor governance and corruption and highly fragmented markets; that consequently compromises the performance of health systems.

Africa’s growing population is faced with significant unmet medical needs. To meet the rising demands, many countries are adopting new models of care such as e-health, public-private partnerships and insurance – to enhance autonomy, improve medicine procurement and increase efficient distribution systems.


Poor governance in health systems increases opportunities for corruption to occur and for mismanagement to go undetected. Pharmaceutical systems are particularly susceptible to fraudulent practices due to weak institutional and enforcement controls[2]. leading to financial losses, unavailability of medicines and poor service delivery across the pharmaceutical management process.

The ensuing challenges faced, has made it imperative for all relevant stakeholders to work towards improving supply chains across Africa by integrating, collaborating, optimising, and enhancing technologies, skills, and infrastructure.

Working with partners, the Anadach Group will host a webinar to engage key players in Africa to discuss how they can strengthen governance across the healthcare supply chain. These stakeholders will be representative of various geographies as well as various key components across the pharmaceutical value chain. The discussants at the webinar will address the following questions but will be open to other issues of critical concerns.

  • What are the best practices for managing and sharing information across the supply chain?

  • How can technology improve the practices for managing supply chains from manufacturing to patient delivery?

  • How can high quality and safe drugs, products and supplies be consistently delivered – irrespective of source?

  • How can key stakeholders influence policies and legislation that promote safe pharmaceutical practices in a rapidly growing space?

  • How can organizations and companies ensure adequate and appropriate human capacity across the entire pharmaceutical value chain to enhance performance and ethical practices?

  • How can boards be more accountable and responsible towards stakeholders and promote sustainable healthcare solutions across the supply chain?

  • How can good governance practices be incorporated into systems and processes across the Supply Chain?


Please register to participate. And do share with relevant colleagues. Thank you.


Opening Remarks: Mr Olaf Schmidt , Manager . Health, Education, Tourism, Retail, Property Investments – Africa, International Finance Corporation

Special Guest: HE. Mr.  Udom  Emmanuel,  Governor Akwa Ibom, Nigeria (Host of Jubilee Syringes – largest syringe manufacturing plan in Africa)

Guest Speaker: Dr. James A. Rice; Ph.D., FACHE,  Senior Advisor, Governance and Leadership, Gallagher Human Resources & Compensation Consulting, Minneapolis, US; Advisory Board Member, Anadach Group




  • 14:00 – 14:05 Introduction and welcome – Anadach Group, View Presentation

  • 14.05 – 14:10  Opening Remarks Mr. Olaf Schmidt , Manager . Health, Education, Tourism, Retail, Property Investments – Africa, International Finance Corporation, View Presenation

  • 14.10 - 14.20  H.E. Mr. Udom Emmanuel, Governor Akwa Ibom, Nigeria

  • 14:20– 14:35  Governance across Supply Chains  Dr. James Rice, View Presentation

  • 14:35 – 14:55  Panel discussion

  • What are the best practices for managing and sharing information across the supply chain?

  • How can high quality and safe drugs, products and supplies be consistently delivered – irrespective of source?

  • How can key stakeholders influence policies and legislation that promote safe pharmaceutical practices in a rapidly growing space?

  • How can boards be more accountable and responsible towards stakeholders and promote sustainable healthcare solutions across the supply chain?

  • How can good governance practices be incorporated into systems and processes across the Supply Chain?

  • View Dr. Mustafa Hunter's Presentation,

  • View Dr. Chiluba Mwila's Presentation,

  • View Mr. Benjamin Kwame Botwe's Presentation

  • 14:55– 15:25 Question and Answer session

  • 15:25 – 15:30 Thanks/Announcements – Anadach Group


HE. Mr.  Udom  Emmanuel,  Governor Akwa Ibom, Nigeria

Special Guest

Mr. Udom Emmanuel is the Governor of Akwa Ibom State, Nigeria since May 29, 2015, is a technocrat and refers to himself as a “professional in politics.”

Until his successful foray into public service, Mr. Emmanuel was a significant member of the  Nigeria’s Financial Services Sector, where at Zenith, one of the largest banks in Nigeria, he was an Executive Director. He was responsible for direct supervision on Foreign Subsidiaries, Corporate Strategy and Planning, Corporate Financial Advisory Services and Control, Business Development, International Investors’ Relations, Oil & Gas Sector, Infrastructure and Power Sector, Multilaterals, Conglomerates and Private Banking (MCP) as well as Telecommunications sector.

Governor Emmanuel graduated from the University of Lagos with a 2nd Class Upper Degree in Accounting and holds a master’s degree in Corporate Governance from Leeds Metropolitan University in the United Kingdom. He is a fellow of the Institute of Chartered Accountants of Nigeria (FCA), Fellow of Institute of Financial Management, as well as Associate Member of the Chartered Institute of Taxation of Nigeria (ACIT).

Governor Emmanuel in the course of his career in the Financial Services Sector  also attended several executive management programmers  across Continents, among them: The Advanced Management Programme (AMP) Insead, France, Advanced Leadership Management Programme, London Business School, Changing the Game: Negotiation and Competitive Decision-Making, Harvard Business School, Enterprise Risk Management & Basel 11, Dun & Bradstreet; Executive  Leadership Programme, Columbia Business School, New York, USA, Strategic Thinking & Management for Competitive Advantage, The Wharton Business School, Pennsylvania, USA.

jimmy rice.JPG

Dr. Jim A. Rice

Special Speaker

Jim Rice, PhD, FACHE is Senior Adviser with the Governance & Leadership service line of Gallagher’s Human Resources & Compensation Consulting practice. He focuses his consulting work on strategic governance structures and systems for high performing, tax-exempt nonprofit, credit union and health sector organizations and integrated care systems; visioning for large and small not-for-profit organizations; and leadership development for Physicians, Boards and C-Suite Senior Leaders. 


Dr. Rice holds masters and doctoral degrees in management and health policy from the University of Minnesota. He has received the University of Minnesota, School of Public Health Distinguished Alumni Leadership Award; a National Institute of Health Doctoral Fellowship; a US Public Health Service Traineeship in Hospital Management; a Bush Leadership Fellowship at Stanford and the National University of Singapore; and the American Hospital Association’s Corning Award for Excellence in Hospital Planning. He is a Fellow in the American College of Healthcare Executives (ACHE). 


Dr. Rice has worked in over 34 countries and was recently Project Director and Global Technical Lead for Governance in a large $200 million USAID funded project serving countries in Asia, Africa, and Latin America. Dr. Rice holds faculty positions at The Strathmore School of Business, Nairobi, Kenya; The Advance Institute for Health Services Management in Prague, the Czech Republic; The Judge School of Business, Cambridge University, Cambridge, England; and the Program in Health Administration at the University of Minnesota’s School of Public Health. He has lectured at the Nelson Mandela School of Medicine in Durban, South Africa; The Thunderbird International School of Management in Arizona; Cornell University; The School of Public Health, University of California Berkeley, and Harvard University. He serves as Chairman for the International Advisory Board for Children’s HeartLink, an organization committed to building cardiac care capacity in developing countries, and Crescent Cove, a respite and hospice service coordinator for children facing life-limiting illnesses. He is on the Dean’s Cabinet for the School of Public Health, University of Minnesota.

Dr. Mustafa Hunter.png

Dr.  Mustafa Hunter


Dr. Mostafa Hunter is an international expert in health systems design and governance with unique expertise in institutional governance, private sector engagement for public value and corruption risk management. His work of over 15 years has been focusing intensively on topics related to safeguarding equity, integrity and responsible investment in healthcare. He has been an advisor to a multiplicity of UN agencies and took the lead on the development of several innovative approaches, conceptual frameworks and guides in health governance related fields. He has been supporting implementations across a diversity of contexts with direct work experiences in around 20 high-, middle- and low-income countries.


 Mostafa is awarded the 2011 Rising Star of Corporate Governance by the Yale School of Management and in 2012 Global Proxy Watch named him a Star. Moreover, he was part of the team awarded the World Bank VPU Team Award of Excellence for 2016. He is also awarded the Cairo University Faculty of Medicine Shield of Honor and the Honor of Outstanding Alumni from the DAAD (German Academic Exchange Service) Alumni Association of Egypt.


He is currently the Founder and President of Health Governance International LLC (HGI), USA and Lead Founder and Chairman of the Healthcare Governance and Transparency Association (HeGTA), Germany. He is Senior Advisor for Corruption Risk Management at UNDP and serves as a member of the Steering Committee of the Coalition for Accountability, Transparency and Anticorruption for Health Alliance, a joint coalition between the WHO, UNDP, Global Fund and World Bank. He is an Honorary Associate to the Institute of Development Studies UK, Guest Lecturer at the Management Center Innsbruck Austria and Member of the Advisory Board of the Health Management Program at the University of New Castle Australia. He served as a member of the Expert Advisory Committee on Governance of the Private Sector for the WHO-HQ.


Mr. Olaf Schmidt

Opening Remarks Speaker

Olaf Schmidt is Manager, Health, Education, Tourism, Real Estate, Retail Investments, Africa Region at IFC (International Finance Corporation, a member of the World Bank Group).


He has done investments across all continents over the past 20+ years. His current responsibilities include amongst others expanding the reach and impact of healthcare investments across the African continent. His previous responsibilities as Hub Lead for MAS (Manufacturing, Agribusiness, Services) in Western Europe included helping build business with European sponsors across emerging markets and providing global coverage of investments with a variety of instruments including equity, mezzanine finance, and debt.


Before joining IFC in 2003, he worked in strategy consulting with A.T. Kearney in France and Germany and spent two years with OTF Group (formerly Monitor Country Competitiveness) in Africa. 


Olaf holds a Business Administration degrees from ESSEC, France and Mannheim University, Germany, and a MPA from the Harvard Kennedy School of Government.

Mr Bramuel Mwalo.jpg

Mr. Bramuel Mwalo


Bramuel Mwalo started off his early career launching and later heading the Business Incubation and Acceleration Centre at KCA University. He was also the first country Managing Director of Global Trade and Technology platform Kountable, managing a budget of $150million (Ksh. 16.5billion). Thereafter, Bramuel served as Director of Africa Business at Kountable, tasked with driving expansion on the continent.
While a PHD candidate at Stockholm school of Economics, Bramuel founded Xetova in 2019, inspired by the need to “empower decision-makers by providing simple solutions to small businesses” by providing data insights led capability to build solutions that spur growth.

Xetova builds capacities for businesses to help them leverage and utilize their data profitably. His journey has been fueled with an unrelenting passion for empowering people and organizations to drive impact. Leveraging the unique lessons learnt from start and leading, a San Francisco based company that saw 250 SMEs access financing in the continent, he continuously innovates winning strategies for African markets and local businesses to scale.

While noting that trends in business are valuable, Bramuel, who also holds a Masters degree in Finance and Banking, emphasizes that traders should not be driven by whims, but that you must be able to understand the context of business in any environment to be able to trade”.

Bramuel’s honors include being recognized as a World Economic Forum Uplink contributor and an MIT Solver fellow due to the exemplary work championed through Xetova.


Chiluba Mwila.jpg

Dr. Chiluba Mwila


Dr. Chiluba Mwila possesses a Ph.D. in Pharmaceutics (Pharmaceutical Technology, Dosage Form Design, and Manufacturing) (focus on novel drug delivery system design, microencapsulation techniques, and assessment of the quality of drug delivery systems with a view to improving tuberculosis patient outcomes – Rhodes University: 2018), and a Master degree in Pharmaceutics (focus on development and assessment of sustained-release antiretroviral dosage forms to improve adherence to antiretroviral therapy in HIV/AIDS patients – Rhodes University: 2013). He graduated from the University of Zambia with a Bachelor of Pharmacy Degree (Merit) in 2008 and he is a registered Pharmacist with almost fourteen years of experience in both public and private sectors. He also has many other professional certificates among them in pharmaceutical supply chain management (PSCM), leadership, management and mentorship, HIV/AIDS management, and is a certified PSCM trainer of trainers (TOT).


He has over 8 years of experience working in the higher education sector as a pharmacy personnel trainer, and over 5 years in education and development, of those 4 years as a freelance consultant in pharmacy manufacturing, curriculum development and implementation with assignments in a number of private companies and universities in Zambia. He has also a part-time lecturer at Eden University and Lusaka Apex Medical University in Zambia in the Faculties of Pharmacy.


He has a specific international expertise on pharmacy education policy analysis, needs-based pharmacy education, with experience as a member of the expert advisory board for academic institution membership (AIM) of the International Pharmaceutical Federation (FIP) which provides policy guidance on pharmacy education and practice in the world.


Dr. Mwila has an extensive and varied experience as a team leader, at both the strategic (having worked as Head of Pharmacy Department at the University of Zambia for almost 4 years) and technical levels (having served as Chairperson of the Expert Advisory Committee for the Zambia Medicines Regulatory Authority Board for two years), and in working for international agencies (as Technical Operations manufacturing Consultant with the United Nations Economic Commission for Africa-UNECA) on the AfCFTA anchored-Pharmaceutical Initiative which is promoting pooled procurement mechanism, harmonized medicines regulation, and local pharmaceutical production in ten selected African countries. He is also a member of the technical working group developing Zambia’s pharmaceutical manufacturing strategy.

Further, he has experience in establishing partnerships between international and local organizations, conducting of needs assessment and development of capacity building programmes, conducting research and postgraduate research student supervision, conducting of workshops and conferences, and publications. He also has experience in working on projects with NGOs such as the Churches Health Association of Zambia, UNFPA, and USAID-GHSC-PSM focusing on strengthening pharmaceutical supply chain management in the public health sector.




Mr. Klutse has over twenty (25) years’ experience in senior and executive management positions and prior to this appointment, he was the Managing Director for Intravenous Infusions Ltd. Earlier to that, he was Head of Finance for Golden Beach Hotels (GH) Limited (A 100% subsidiary company of SSNIT).  He has led finance teams for over ten (10) years in the Pharmaceutical and Healthcare industry in UK and has a specialty in Pharmaceutical Mergers and Acquisitions, Pharmaceutical Due Diligence, Healthcare Vitamins, Minerals & Supplement (VMS), FMCG, Pharmaceutical Start Ups and Pharmaceutical Pricing Regulatory Schemes (PPRS). He was part of the Finance Project team that successfully floated Goldshield Pharmaceuticals Group Plc on the London Stock Exchange in 1997.

In 2001, Mr. Klutse was part of the Goldshield key management team that acquired the assets of Antigen International Limited including all the trademarks, know how, sales, marketing and distribution rights to the products of Antigen. Antigen was a private pharmaceutical company, Incorporated in the Republic of Ireland, which specialized in the production of sterile injectable therapeutic pharmaceutical products to treat a wide range of conditions including Anesthesia and Rheumatology.

Mr. Klutse, has worked for several Footsie (LSE) and Alternative Investment Market (AIM) listed companies in the UK. In 2007, he was appointed Head of Finance at Ingeus UK Limited. Ingeus is the largest Welfare to Work contractor working for the UK Department for Works and Pensions. Our core mandate was to support the unemployed and disabled back to the work place.

Mr. Klutse holds an Executive MBA (Project Management) from the University of Ghana Business School. He completed the Association of Certified Chartered Accountants (ACCA) course in 1999 and was awarded a Fellow (FCCA) of the Association in 2003. Mr. Klutse graduated with a BA (Hons) Accounting & Finance from the London South Bank University.


As the Chief Operating Officer, he is responsible for the strategic and day-to-day management of the company as well as organization of the business of Atlantic Lifesciences Ltd (ALL). He however operates under the overall policy direction of the CEO and the Board of Directors. He coordinates the activities of the Heads of the various departments in order to ensure smooth operation and execution of policies and directives.


He joined the company in June 2020


A member of the Institute of Directors (IoD) Ghana

Executive member of the Pharmaceutical Manufacturers Association of Ghana


MR. Benjamin Kwame Botwe


Benjamin Kwame Botwe, the CEO and Chief Executive Officer and Lead Consultant at BB Associates Limited, is a world renowed expert of Medicines Regulation, Quality Assurance and Pharmaceutical Sector Management.

He also has wide experience in Strategic Management and Public Administration.

 Mr. Botwe has served for the past 35 years at very high levels in the public services of Ghana and Africa.

He is the foundation Deputy Chief Executive(Drugs Division) of the Ghana Food and Drugs Board (now Authority) and acted as Chief Executive from October 2000 to May 2001.  He is the first Pharmacist and civilian to have served as the Executive Secretary of the Narcotics Control Board of  Ghana and also served as Rector of the Ghana College of Pharmacists from where he retired from public service in 2019. Over the period of his career, he has been involved in the developemnt of Medicines Control and Regulatory Services by way of policy and legislation development, drafting of regulatory guidelines and procedures and trainng and capacity building in many African countries including Ghana, Botswana, Rwanda, Mozambique, Eritrea, Liberia, Sierra Leone, The Gambia, Namibia, The Comoros, The Seychelles, Madagascar and Malawi. Mr Botwe had been a Consultant to the Medicines and Vaccines Program of the West Africa Health Organization (WAHO) and the AU NEPAD African Medicines Registration Harmonizaion (AMRH) Project. Ben has undertaken several international consultancies with other renowned agencies like the USAID, PEPFAR, EU, USP, MANAGEMENT SCIENCES FOR HEALTH, TRANSEC, GIZ and WHO.

Between 2012 and 2017 he was appointed a Short Term Consultant (STC) by the World Bank to faclitate the harmonization of medicines regulation in the ECOWAS Region. Mr Botwe was a Faculty member and lectured at the Centre for Pharmaceutical Advancement and Training (CePAT) (now USP Ghana) and also teaches part of the Pharmacy Practice Regulation Course for the West Africa Postgraduate College of Pharmacists. He has in his carrer served on the Board of the Pharmacy Council, Seriuos Fraud Office (SFO) (now EOCO), the Presbyterian Health Services, The National Medicines Policy Committeee, the African Expert Group on Pharmaceuticals for the USP, and represented the Pharmaceutical Society of Ghana (PSGH) as an observer on the USP Commission.

Mr. Botwe holds a Bachelor of Pharmacy honours degree from KNUST, Master of Science in Pharmaceutical Analysis from the University of Strathclyde in Glasgow, UK, Master of Public Administration from GIMPA, Accra, Post Graduate certificate in Strategic Leadership from MSH, Boston, Post Graduate Certificate in Managing Analytical Laboratories from the University of North West in South Africa. Mr. Botwe is a Member of the Pharmaceutical Society of Ghana, Fellow of the Ghana College of Pharmacists, Fellow of the West African Post-graduate College of Pharmacists and a Member of the International Federation of Pharmacists (FIP). He has authored and/ or co-authored over twelve publication in the field of medicines regulation and quality assurance and has been cited in several publications. He has attended several Conferences in the area at several of which he has been speaker, modertor or chair of specific sessions.

Mr. Botwe is the immediate Past President of the Pharmaceutical Society of Ghana, Chairman of the Faculty of Drug Production and Quality Assurance of the West African Post-graduate College of Pharmacists and a member of the General Assembly Council of the Presbyterian Church of Ghana

bottom of page